| JYSB2400110 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-05-17 | | Sanofi Winthrop Industrie | | | view |
| JXSS2500056 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-13 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSL2200187 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-10-27 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd | | | view |
| JXSS2500062 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-21 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSS2300010 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-01-12 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSL2400169 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-09-14 | | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | | | view |
| JXSS2400003 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-01-25 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYSB2500076 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2025-03-25 | | Sanofi Winthrop Industrie | | | view |
| JXSS2101005 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-05-10 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYSB2400109 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-05-17 | | Sanofi Winthrop Industrie | | | view |
| JXSS2500059 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-13 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSL2101140 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-11-30 | | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | | | view |
| JXSS2500063 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-21 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSS2300007 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-01-12 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSL2400123 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-07-12 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSS2400002 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-01-25 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYSB2500069 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2025-03-19 | | Sanofi Winthrop Industrie | | | view |
| JYSB2200207 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-10-22 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
| JXSS2500057 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-13 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYSB2200208 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-10-22 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
